Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Azusa Tanimoto"'
Autor:
Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, Fumiyoshi Ohyanagi, Yosuke Kawashima, Yuichi Tambo, Azusa Tanimoto, Atsushi Horiike, Eisaku Miyauchi, Yuko Tsuchiya‐Kawano, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 13, Iss 10, Pp 1471-1478 (2022)
Abstract Background Dacomitinib is the second‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitor (TKI) for mutant non–small cell lung cancer (NSCLC). EGFR‐TKIs are often re‐administered in Japan after the disease p
Externí odkaz:
https://doaj.org/article/5e5f715847fd4a66aa35dd6d0e976bda
Autor:
Naohiro Yanagimura, Shinji Takeuchi, Koji Fukuda, Sachiko Arai, Azusa Tanimoto, Akihiro Nishiyama, Naohisa Ogo, Hiroyuki Takahashi, Akira Asai, Satoshi Watanabe, Toshiaki Kikuchi, Seiji Yano
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Patients with advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer who are prescribed ALK-tyrosine kinase inhibitors (ALK-TKIs) rarely have complete responses, with residual tumors relapsing as heterogeneous resist
Externí odkaz:
https://doaj.org/article/96cbee869e9e46158e3c0f9d71481295
Autor:
Rong Wang, Tadaaki Yamada, Kenji Kita, Hirokazu Taniguchi, Sachiko Arai, Koji Fukuda, Minoru Terashima, Akihiko Ishimura, Akihiro Nishiyama, Azusa Tanimoto, Shinji Takeuchi, Koshiro Ohtsubo, Kaname Yamashita, Tomoyoshi Yamano, Akihiro Yoshimura, Koichi Takayama, Kyoichi Kaira, Yoshihiko Taniguchi, Shinji Atagi, Hisanori Uehara, Rikinari Hanayama, Isao Matsumoto, Xujun Han, Kunio Matsumoto, Wei Wang, Takeshi Suzuki, Seiji Yano
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Cancer cells develop resistance to tyrosine kinase inhibitors targeting EGFR. Here, the authors explore the mechanism of resistance to one such inhibitor - osimertinib - and find that resistance is caused by increased expression and activation of the
Externí odkaz:
https://doaj.org/article/286176aadbbc411dbfd32550becc33c5
Autor:
Yuta Adachi, Naohiro Yanagimura, Chiaki Suzuki, Sakiko Ootani, Azusa Tanimoto, Akihiro Nishiyama, Kaname Yamashita, Koushiro Ohtsubo, Shinji Takeuchi, Seiji Yano
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-4 (2020)
Abstract Background A BRAF V600E mutation is found as driver oncogene in patients with non-small cell lung cancer. Although combined treatment with dabrafenib and trametinib is highly effective, the efficacy of reduced doses of the drugs in combinati
Externí odkaz:
https://doaj.org/article/248ccedf4c7e4010a00b7c2f3c8a2c40
Autor:
Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang, Keiko Tanimura, Yuta Adachi, Akihiro Nishiyama, Azusa Tanimoto, Shinji Takeuchi, Luiz H. Araujo, Mariana Boroni, Akihiro Yoshimura, Shinsuke Shiotsu, Isao Matsumoto, Satoshi Watanabe, Toshiaki Kikuchi, Satoru Miura, Hiroshi Tanaka, Takeshi Kitazaki, Hiroyuki Yamaguchi, Hiroshi Mukae, Junji Uchino, Hisanori Uehara, Koichi Takayama, Seiji Yano
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
Resistance to the new generation EGFR-TKI, Osimertinib, can emerge in patients with EGFR-mutated lung cancer. Here, the authors show that AXL, which is activated by osimertinib, can promote the emergence of tolerant lung cancer cell thus conferring r
Externí odkaz:
https://doaj.org/article/56fa97cab04d4e0d8784ee4ba0940412
Autor:
Azusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani, Kaname Yamashita, Tadaaki Yamada, Koushiro Ohtsubo, Hiromichi Ebi, Hiroko Ikeda, Seiji Yano
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-4 (2018)
Abstract Background Pulmonary carcinosarcoma (PCS) is a rare primary lung malignancy and has a poor prognosis among lung tumor histological subtypes. However, an appropriate treatment strategy has not been developed for unresectable PCS. Case present
Externí odkaz:
https://doaj.org/article/7a69227862094f0caf65786b14b15e03
Autor:
Koushiro, Ohtsubo, Kunio, Miyake, Sachiko, Arai, Koji, Fukuda, Chiaki, Suzuki, Hiroshi, Kotani, Azusa, Tanimoto, Akihiro, Nishiyama, Shigeki, Nanjo, Kaname, Yamashita, Shinji, Takeuchi, Seiji, Yano
Publikováno v:
Cancer Diagn Progn
Background/Aim: We previously reported the usefulness of aberrant methylation of tumor suppressive miRNAs in bile to discriminate pancreaticobiliary cancers (PBCs) from benign pancreaticobiliary diseases (BD). Here we performed a methylation analysis
Autor:
Seiji Yano, Shu Taira, Eishu Hirata, Naoyoshi Onoda, Junji Matsui, Koshiro Ohtsubo, Kaname Yamashita, Shinji Takeuchi, Akihiro Nishiyama, Azusa Tanimoto, Hirokazu Taniguchi, Koji Fukuda, Sachiko Arai, Tadaaki Yamada, Rong Wang
Supplementary Figure 3 shows the activation of cell cycle-, and apoptosis-related proteins treated with lenvatinib or sorafenib in OCUT-1C and OCUT-2 cell subcutaneous tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3057b7ae8e1735ca56bc2a2870be24b9
https://doi.org/10.1158/1535-7163.22509396
https://doi.org/10.1158/1535-7163.22509396
Autor:
David P. Carbone, Konstantin Shilo, Seiji Yano, Cynthia Timmers, Takehito Shukuya, Hirokazu Taniguchi, Azusa Tanimoto, Joseph M. Amann, Tadaaki Yamada
Sup Figure legend 1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f99af27790c86e5bc53ffdf6c0d1832
https://doi.org/10.1158/1535-7163.22504818
https://doi.org/10.1158/1535-7163.22504818
Autor:
Seiji Yano, Shu Taira, Eishu Hirata, Naoyoshi Onoda, Junji Matsui, Koshiro Ohtsubo, Kaname Yamashita, Shinji Takeuchi, Akihiro Nishiyama, Azusa Tanimoto, Hirokazu Taniguchi, Koji Fukuda, Sachiko Arai, Tadaaki Yamada, Rong Wang
Supplementary Table 2 shows the production of angiogenesis-related cytokines in the supernatant of ATC cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426278cdefb9e5e4873e9f4d9a243030
https://doi.org/10.1158/1535-7163.22509378
https://doi.org/10.1158/1535-7163.22509378